㳿 ..

³    Facebook

 

:

,

,

,

,

,

- ,

:

:

" " (),
" " (),
" " ()
"&ճ"
()

:

,

:

, ,
,
,

:

:

-

ϳ :

,

,

,
,

:

', ,

:

, ,  

:

,

:


26.552.01:

2021 - 1.
̲ / / CONTENTS

 

/ EDITORIAL

 

DOI: 10.31215/2306-4927-2021-29-1-5-14
. . , . . , . . , . . , . . , . . ˳
Ҳ COVID-19

Y. I. Feshchenko, O. A. Golubovska, A. Y. Dziublyk, V. K. Gavrysyuk, Y. A. Dziublyk, I. V. Liskina
PULMONARY DISEASE IN COVID-19

 

 

òͲ Ҳ / ORIGINALS

 

DOI: 10.31215/2306-4927-2021-29-1-15-21
. . , . . , . . , . . , . . , . . , . .
̲Ͳ Ҳί ղ̲ϲ ϲ Ͳ ²-вί Ҳò

O. Ya. Dziublyk, G. B. Kapitan, O. O. Mukhin, R. E. Sukhin, V. A. Yachnyk, O. V. Denisova, Yu. O. Slesarenko
PHARMACOECONOMIC ASPECTS OF ETIOTROPIC CHEMOTHERAPY FOR PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA OF VIRAL-BACTERIAL ETIOLOGY

 

DOI: 10.31215/2306-4927-2021-29-1-22-25
. . , . . , . . , . . , . . , . . , . . , . . , . .
Ͳ ̲ ˲Ͳ ί ²

V. K. Gavrysyuk, Y. O. Dziublyk, I. O. Merenkova, G. L. Gumeniuk, N. A. Vlasova, N. V. Pendalchuk, N. D. Morska, A. I. Iachnik, S. I. Leshchenko
EFFICACY AND TOLERABILITY OF METHOTREXATE IN TREATMENT OF PATIENTS WITH PULMONARY SARCOIDOSIS DEPENDING ON THE DOSE OF THE DRUG

 

DOI: 10.31215/2306-4927-2021-29-1-26-30
. . , . . , . . , . . , . . , . . , . . , . . , . .
̲Ͳ ղò ղò ˲

M. S. Opanasenko, M. I. Kalenichenko, V. I. Lysenko, O. V. Tereshkovich, B. M. Konik, L. I. Levanda, M. Y. Shamrai, S. M. Shalagai, S. M. Bilokon
RESULTS OF THE USE OF MINI-INVASIVE SURGERY AS A METHOD OF SURGICAL TREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS

 

 

˲ / REVIEW

 

DOI: 10.31215/2306-4927-2021-29-1-3138
. . , . . , . .
ֲͲ ί ϲ ֲҲ ֲ ղ в ̲ COVID-19

Y. O. Dziublyk, O. L. Bororova, Y. O. Patiuk
EXPEDIENCY AND SAFETY OF NEBULIZER THERAPY IN PATIENTS WITH INFECTIOUS DISEASES OF THE RESPIRATORY TRACT DURING COVID-19 PANDEMIC

 

в -ί ֲ / PROCEEDINGS OF THE CONFERENCE

 

DOI: 10.31215/2306-4927-2021-29-1-39-42
. .
2020: ² Ͳ ˲

T. O. Pertseva
ASTHMA 2020: NEW GLOBAL RESEARCH DATA
 

DOI: 10.31215/2306-4927-2021-29-1-43-45
. .
,

L. A. Yashin
DIFFICULT-TO-TREAT, SEVERE ASTHMA
 

 

DOI: 10.31215/2306-4927-2021-29-1-46-47
. .
ղ ̲ COVID-19: SMART-ò

M. M. Ostrovsky
ASTHMA DURING COVID-19 PANDEMIC: SMART-THERAPY FOR ASTHMA CONTROL AND PREVENTION OF EXACERBATIONS
 

DOI: 10.31215/2306-4927-2021-29-1-48-50
. .
Ҳ ղί в ̲ COVID-19

S. V. Zaikov
POSSIBILITIES TO IMPROVE ASTHMA CONTROL DURING THE COVID-19 PANDEMIC
 

DOI: 10.31215/2306-4927-2021-29-1-51-53
. . , . .
ί

Yu. M. Mostovoy, O. V. Bugaychuk
MILD ASTHMA SEVERE PROBLEM FOR THE PRIMARY CARE
 

DOI: 10.31215/2306-4927-2021-29-1-54-55
. . , . .
--: Ͳ ?

Yu. M. Mostovoy, O. V. Bugaychuk
ASTHMA-HEART-VESSELS: COMORBID CONDITIONS?

 

DOI: 10.31215/2306-4927-2021-29-1-56-58
. .
ò ղί : IJ ˲

S. V. Zaikov
ALLERGIC PHENOTYPE OF ASTHMA: NUANCES OF DIAGNOSIS AND TREATMENT
 

DOI: 10.31215/2306-4927-2021-29-1-59-61
. .
² Ͳ ղί : ̲ ί ϲ

K. Yu. Gashynova
EMERGENCY CARE FOR EXACERBATION OF ASTHMA: PLACE FOR NEBULIZER THERAPY
 

DOI: 10.31215/2306-4927-2021-29-1-62-64
. . , . . , . . , . .
ղ ˲

N. S. Slepchenko, K. D. Dmitriev, N. V. Tsymbalyuk, Yu. M. Mostovoy
ASTHMA AND SMOKING
 

DOI: 10.31215/2306-4927-2021-29-1-65-68
. .
?

L. V. Yudina
ARE ANTIBIOTICS NECESSARY IN ASTHMA EXACERBATION?
 

DOI: 10.31215/2306-4927-2021-29-1-69-70
. .
̲ ֲ (FENO) ²в, : ˲?

K. Yu. Gashynov
MEASUREMENT OF NITROGEN OXIDE FRACTION (FENO) IN THE EXHALED AIR: WHAT SHOULD A PRACTITIONER KNOW?
 

DOI: 10.31215/2306-4927-2021-29-1-71-74
. .
ղ ֲ Ѳ ˲ ֲ

A. V. Demchuk
ASTHMA FROM THE POINT OF VIEW OF GENERAL RACTITIONER AND PATIENT
 

 

 


Home
ϳ  
I


, , Ͳ , .
'!

³
Ͳ

 E-mail

www.ifp.kiev.ua